Srilatha Tangada

Randomized comparison of prophylaxis and on‐demand regimens with <scp>FEIBA NF</scp> in the treatment of haemophilia A and B with inhibitors

Sandra Vallin Antunes, Srilatha Tangada, Oleksandra Stasyshyn et al. · Haemophilia · 2013 · 115 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Rurioctocog alfa pegol PK-guided prophylaxis in hemophilia A: results from the phase 3 PROPEL study

Robert Klamroth, Jerzy Windyga, Vlad C. Radulescu et al. · Blood · 2020 · 77 citations · Full text

Medicine, Hematology, Pharmacology +7

The Effect of Smoking on Serum IgG2 Reactive With <i>Actinobacillus actinomycetemcomitans</i> in Early‐Onset Periodontitis Patients

Srilatha Tangada, Joseph V. Califano, Keisuke Nakashima et al. · Journal of Periodontology · 1997 · 66 citations

Dentistry, Immunology, Periodontology +17

Pro‐ and anticoagulant factors facilitate thrombin generation and balance the haemostatic response to FEIBA^® in prophylactic therapy

Katalin Váradi, Srilatha Tangada, M. Loeschberger et al. · Haemophilia · 2016 · 36 citations · Full text

Medicine, Hematology, Pharmacology +17

Long‐term safety and efficacy results from the phase 3b, open‐label, multicentre Continuation study of rurioctocog alfa pegol for prophylaxis in previously treated patients with severe haemophilia A

Pratima Chowdary, Eric S. Mullins, Barbara A. Konkle et al. · Haemophilia · 2020 · 34 citations · Full text

Medicine, Hematology, Pharmacotherapy +14